Pathological roles of ganglioside mimicry in guillain-barré syndrome and related neuropathies

Advances in Experimental Medicine and Biology

Volumn 705, Issue , 2011, Pages 349-365

  Yu, Robert K ^a   Ariga, Toshio ^b   Usuki, Seigo ^b   Kaida, Ken Ichi ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

Antiganglioside antibodies; Autoantibodies against ganglioside complex; Campylobacter jejuni; Guillain Barr syndrome; Lipopolysaccharides; Molecular mimicry

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE ANTIBODY; VOLTAGE GATED SODIUM CHANNEL; BIOLOGICAL MARKER; GANGLIOSIDE GM1; LIPOPOLYSACCHARIDE; PHOSPHOLIPID ANTIBODY;

CONFERENCE PAPER; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOLOGY; MOLECULAR MIMICRY; MOLECULAR PATHOLOGY; NERVE CONDUCTION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANVIER NODE; ARTICLE; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; CHEMISTRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MYELIN SHEATH; NERVE FIBER; PATHOLOGY; PHYSIOLOGY;

ANTIBODIES, ANTIPHOSPHOLIPID; AXONS; BIOLOGICAL MARKERS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; G(M1) GANGLIOSIDE; GUILLAIN-BARRE SYNDROME; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR MIMICRY; MYELIN SHEATH; NEUROMUSCULAR JUNCTION; RANVIER'S NODES;

EID: 80054021668     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7877-6_17     Document Type: Conference Paper

References (67)

1. Ang CW, Jacobs BC, Laman JD (2004) The Guillain-Barre syndrome: acute cases of molecular mimicry. Trends Immunol 25:61-66
2. Apostolski S, Sadiq SA, Hays A, Corbo M, Suturkova-Milosevic L, Chaliff P, Stefansson K, LeBaron RG, Ruoslahti E, Hays AP (1994) Identification of Gal (beta 1-3) GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res 38:134-141
3. Arasaki K, Kusunoki S, Kudo N, Kanazawa I (1993) Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 16:587-593
4. Ariga T, Miyatake T, Yu RK (2001) Recent studies on the roles of anti-glycosphingolipids in the pathogenesis of neurological diseases. J Neurosci Res 65:363-370
5. Ariga T, Yu RK (2005) Antiganglioside antibodies in Guillain-Barre syndrome and related diseases: review of clinical features and antibody specificities. J Neurosci Res 80:1-17
6. Brinkmeier H, Wollinsky KH, Hulser PJ, Seewald MJ, Mehrkens HH, Komhuber HH, Rudel R (1992) The acute paralysis in Guillain-Barr syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid. Pflugers Arch 421:552-557
7. Chiba A, Kusunoki S, Shimizu T, Kanazawa I (1992) Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 31:677-679
8. Corbo M, Quattrini A, Latov N, Hays AP (1993) Localization of GM1 and Gal(beta1-3) GalNAc antigenic determinants in peripheral nerve. Neurology 43:809-814
9. Corbo M, Quattrini A, Lugaresi A, Santoro M, Latov N, Hays AP (1992) Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol 32: 487-493
10. Freddo L, Ariga T, Saito M, Macala LC, Yu RK, Latov N (1985) The neuropathy of plasma cell dyscrasia: binding of IgM M-proteins to peripheral nerve glycolipids. Neurology 35:1420-1424
11. Gilbert M, Brisson JR, Karwaski MF, Michniewicz J, Cunningham AM, Wu Y et al (2000) Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384. Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-MHz 1H and 13C NMR analysis. J Biol Chem 275:3896-3906
12. Gong Y, Lunn MP, Heffer-Lauc M, Li CY, Griffin JW, Schnaar RL et al (2001) Localization of major gangliosides in the PNS: implications for immune neuropathies. J Peripher Nerv Syst 6:142
13. Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J et al (1999) Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest 104:697-708
14. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrick B et al (2001) Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56:758-765
15. Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axo-lemma. Ann Neurol 40:635-644
16. Hahn AF (1998) Guillain-Barre syndrome. Lancet 352:635-641
17. Hakomori SI (1990) Bifunctional role of glycosphingolipids modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265:18713-18716
18. Hakomori SI (2000) Cell adhesion/recognition and signal transduction through glycosphingo-lipid microdomain. Glycoconj J 17:143-151
19. Hakomori SI (2003) Structure, organization, and function of glycosphingolipids in membrane. Curr Opin Hematol 10:16-24
20. Halstead SK, Morrison I, O'Hanlon GM, Humphreys PD, Goodfellow JA, Plomp JJ, Willison HJ (2005) Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia 52:177-189
21. Hartung HP, Pollard ID, Harver GK, Toyka KV (1995) Immunopathogenesis and treatment of the Guillain-Barre syndrome. Muscle Nerve 18:137-153
22. Ho TW, Willlison HJ, Nachamkin I, Li CY, Veitch J, Ung H, Wang GR, Liu RC, Asbury AK, Griffin JW, McKhann GM (1999) Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome. Ann Neurol 45:168-173
23. Hughes RA, Cornblath CR (2005) Guillain-Barre syndrome. Lancet 366:1663-1666
24. Illa LN, Ortiz N, Gallard E, Juarrez C, Gru JM, Dalakas MC (1995) Acute axonal Guillain-Barre syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 38:218-224
25. Iwabuchi K, Handa K, Hakomori SI (1998) Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem 273:33766-33773
26. Jacobs BC, Bullens RW, O'Hanlon GM, Ang CW, Willison HJ, Plomp JJ (2002) Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barre syndrome. Muscle Nerve 25:549-558
27. Kaida K, Kanzaki M, Morita D, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S (2006) Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 77:1043-1046
28. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I (2003) GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody. Neurology 61:465-470
29. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S (2004) Ganglioside complexes as new target antigens in Guillain-Barre syndrome. Ann Neurol 56:567-571
30. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S (2007) Anti-ganglioside complex antibodies associated with severe disability in GBS. J Neuroimmunol 182:212-218
31. Kanzaki M, Kaida K, Ueda M, Morita D, Hirakawa M, Motoyoshi K, Kamakura K, Kusunoki S (2008) Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes. J Neurol Neurosurg Psychiatry 79:1148-1152
32. Koga M, Yuki N, Ariga T, Morimatsu M, Hirata K (1998) Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness of oropharyngeal palsy in Guillain-Barre syndrome? J Neuroimmunol 86:74-79
33. Kuwabara S, Yuki N, Koga M, Hattori T, Matsura D, Miyake M, Noda M (1998) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome. Ann Neurol 44:202-208
34. Melendez-Vasquez C, Redford J, Choudhary PP, Gray IA, Maitland P, Gregson NA, Smith KJ, Hughes RA (1997) Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 73:124-134
35. Moran AP, Annuk H, Prendergast MM (2005) Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipopolysaccharides recognizes epitopes at the nodes of Ranvier. J Neuroimmunol 165:179-185
36. Moran AP, Prendergast MM (2001) Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun 16:241-265
37. Nakatani Y, Kawakami K, Nagaoka T, Utsunomiya I, Tanaka K, Yoshino H, Miyatake T, Taguchi K (2007) Ca2+ Channel currents inhibited by serum from select patients with Guillain-Barre syndrome. Eur Neurol 57:11-18
38. O'Hanlon GM, Plomp JJ, Chakrabati M, Morrison J, Wagner EA, Goodyear CS, Yin X, Trapp RD, Corner J, Molenear PC, Stevant S, Rowan FG, Willison HJ (2001) Anti-GQ1b ganglioside antibodies mediated complement-dependent destruction of the motor nerve terminal. Brain Res 124:893-906
39. Pestronk A, Adams RN, Clawson L, Cornblath D, Kuncl RW, Griffin D, Drachman DB (1988) Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology 38: 1457-1461
40. Santafe MM, Sabate MM, Garcia N, Ortiz N, Lamuza MA, Tomas J (2005) Changes in the neuromuscular synapse induced by an antibody against gangliosides. Ann Neurol 57:396-407
41. Schluep M, Steck AJ (1988) Immunostaining of motor nerve terminals by IgM M protein with activity against ganglioside GM1 and GD1b from a patient with motor neuron disease. Neurology 38:1890-1892
42. Schwerer B (2002) Antibodies against gangliosides: a link between preceding infection and immuno-pathogenesis of Guillain-Barre syndrome. Microbes Infect 4:373-384
43. Sheikh KA, Deerinck TJ, Ellisman MH, Griffin JW (1999) The distribution of ganglioside-like moieties in peripheral nerves. Brain 122:449-460
44. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31-39
45. Taguchi K, Ren J, Utsunomiya I, Aoyagi H, Fujita N, Ariga T, Miyatake T, Yoshino H (2004) Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies -effects on neuromuscular transmission. J Neurol Sci 225:91-98
46. Taguchi K, Utsunomiya I, Ren J, Yoshida N, Aoyagi H, Nakatani Y, Ariga T, Usuki S, Yu RK, Miyatake T (2004) Effect of rabbit anti-asialo-GM1 (GA1) polyclonal antibodies on neuro-muscular transmission and acetylcholine-induced action potentials: neurophysiological and immunohistochemical studies. Neurochem Res 29:953-960
47. Takigawa T, Yasuda H, Kikkawa R, Shigeta Y, Saida T, Kitasato H (1995) Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann Neurol 37:436-442
48. Thomas FP, Trojaborg W, Nagy C, Santoro M, Sadiq SA, Latov N, Hays AP (1991) Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol 82:378-382
49. Trojaborg W (1998) Acute and chronic neuropathies: new aspects of Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy, an overview and an update. Electroencephalogr Clin Neurophysiol 107:303-316
50. Usuki S, Nakatani Y, Taguchi K, Fujita T, Tanabe S, Utsunomi I, Gu YH, Cawthraw S, Newell D, Pajaniappan M, Thompson S, Ariga T, Yu RK (2008) Topology and patch-clamp analysis of the sodium channel in relationship to the anti-lipid A antibody in campylobacteriosis. J Neurosci Res 86:3359-3374
51. Usuki S, Sanchez J, Ariga T, Utsunomiya I, Taguchi K, Rivner MH, Yu RK (2005) AIDP and CIDP having specific antibodies in carbohydrate (-NeuAca2-8NeuAca2-3Gal1-4Glc-) of gangliosides. J Neurol Sci 232:37-44
52. Usuki S, Thompson SA, Rivner MH, Taguchi K, Shibata K, Ariga T, Yu RK (2006) Molecular mimicry: sensitization of Lewis rats with Camplyobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside. J Neurosci Res 83:274-284
53. Weber F, Rudel R, Aulkemeyer P, Brinkmeier H (2000) Anti-GM1 antibodies can block neuronal voltage-gated sodium channels. Muscle Nerve 23:1414-1420
54. Willison HJ (2005) The immunology in Guillain-Barre syndrome. J Peripher Nerv Syst 10:94-112
55. Willison HJ (2005) Ganglioside complexes: new autoantibody targets in Guillan-Barre syndromes. Nat Clin Pract Neurol 1:2-3
56. Willison HJ, O'Hanlon GM, Paterson G, Veitch J, Wilson G, Roberts M et al (1996) A somati-cally mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest 97:1155-1164
57. Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591-2625
58. Wutrz A, Brinkmeier H, Wollinsky KH, Mehrkens HH, Kornhuber HH, Rudel R (1995) Cerebrospinal fluid and serum from patients with polyradiculoneuropathy have opposite effects on sodium channels. Muscle Nerve 18:772-781
59. Yoshino H, Harukawa H, Asano A (2000) IgG antiganglioside antibodies in Guillain-Barre syndrome with bulbar palsy. J Neuroimmunol 105:195-201
60. Yoshino H, Utsunomiya I, Taguchi K, Ariga T, Nagaoka T, Aoyagi H, Asano A, Yamada M, Miyatake T (2005) GalNAc-GD1a is localized specifically in ventral spinal roots, but not in dorsal roots. Brain Res 1057:177-180
61. Yu RK (1994) Developmental regulation of ganglioside metabolism. Prog Brain Res 101:31-44
62. Yu RK, Ariga T, Yanagisawa M, Zeng G (2008) Biosynthesis and degradation of gangliosides in the nervous system. In: Fraser-Reid B, Tatsuka K, Thiem J (eds) Glycoscience. Springer, Berlin, pp 1671-1695
63. Yu RK, Usuki S, Ariga T (2006) Ganglioside molecular mimicry and its pathological roles in Guillain-Barre syndrome and related diseases. Infect Immun 74:6517-6527
64. Yuki N (2007) Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 35:691-711
65. Yuki N, Ho TW, Tagawa Y, Koga M, Li CY, Hirata K, Griffin JW (1999) Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China. J Neurol Sci 164:134-138
66. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, Tai T, Handa S, Miyatake T (1993) A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 gan-glioside-like structure. J Exp Med 178:1771-1775
67. Yuki N, Taki T, Takahashi M, Saito K, Tai T, Miyatake T, Handa S (1994) Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect Immun 62:2101-2103